Skip to main content
TipRanks
Go Ultimate75% OFF

Michael Clayman Insider Profile

11 Followers

Michael Clayman, Director at Akebia Therapeutics, holds 0.00 shares in Akebia Therapeutics (Ticker: AKBA), holds 0.00 shares in Flexion Therapeutics (Ticker: ~FLXN).

Michael Clayman's Trading History

~FLXN
Flexion Therapeutics
Nov 19, 2021―Uninformative Sell9.54M$0.00
AKBA
Akebia Therapeutics
―Director―$0.00

You May Also Like

Michael Clayman insider profile FAQ

What is the percentage of profitable transactions made by Michael Clayman?
The percentage of profitable transactions made by Michael Clayman is 59%.
What is the average return per transaction made by Michael Clayman?
The average return per transaction made by Michael Clayman is 19.50%.
What stocks does Michael Clayman hold?
Michael Clayman holds: AKBA, ~FLXN stocks.
What was Michael Clayman's most profitable transaction?
Michael Clayman’s most profitable transaction was an Informative Buy of ~FLXN stock on May 23, 2016. The return on the trade was 84.80%.
What is Michael Clayman's role in Akebia Therapeutics?
Michael Clayman's role in Akebia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.